autologous dendritic cell-adenovirus p53 vaccine
Term · Oncology and biomedicine · MLC-T-ONC-011601
An autologous vaccine composed of dendritic cells (DC) that have been transduced with a p53 tumor suppressor gene-modified virus. When the autologous dendritic cell-adenovirus p53 vaccine is administered, the host cytotoxic T lymphocytes (CTL) are directed against p53-positive tumor cells, which may result in tumor cell death and decreased tumor growth.
| Identifier | MLC-T-ONC-011601 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011601",
"term": "autologous dendritic cell-adenovirus p53 vaccine",
"field": "Oncology and biomedicine",
"definition": "An autologous vaccine composed of dendritic cells (DC) that have been transduced with a p53 tumor suppressor gene-modified virus. When the autologous dendritic cell-adenovirus p53 vaccine is administered, the host cytotoxic T lymphocytes (CTL) are directed against p53-positive tumor cells, which may result in tumor cell death and decreased tumor growth.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-dendritic-cell-adenovirus-p53-vaccine/"
}
Record 2,935 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.